Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
MDR TB
Namibia
TB
antimicrobial resistance
bacteria
bedaquiline
respiratory infections
tuberculosis
tuberculosis and other mycobacteria
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
medline:
26
2
2024
pubmed:
26
2
2024
entrez:
26
2
2024
Statut:
ppublish
Résumé
Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk for bedaquiline resistance development and the need for rapid drug-resistance testing.
Identifiants
pubmed: 38407158
doi: 10.3201/eid3003.240134
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM